---
title: CapFusion Labs vs Merck KGaA
slug_a: capfusion-labs
slug_b: merck-kgaa
site: cdmo
review_signal_gate: closed
canonical_path: /compare/capfusion-labs/merck-kgaa
---

# CapFusion Labs vs Merck KGaA

Side-by-side profile data from each company listing on this directory.

## CapFusion Labs

- Profile: [/companies/capfusion-labs](/companies/capfusion-labs)

CapFusion Labs — CapFusion Labs is a specialty capsule manufacturer and development business for complex supplement formats, offering liquid-filled hard capsules, capsule-in-capsule, beadlets-in-liquid, and dry multiparticulate architectures with integrated development, manufacturing, quality documentation, and packaging coordination.

Services: 0. Modalities: 0. Indications: 0. Locations: 2. Certifications: 4. The strongest documented coverage currently appears in certifications (4).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Drug Product (DP)
- Oral Solid Dose (OSD)

## Merck KGaA

- Profile: [/companies/merck-kgaa](/companies/merck-kgaa)

Merck KGaA — Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.

Services: 0. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in locations (1).

### Services

- Data not yet provided.

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.